0
Amisulpride, an Unusual “Atypical” Antipsychotic: A Meta-Analysis of Randomized Controlled Trials
Stefan Leucht, M.D.; Gabi Pitschel-Walz, Ph.D.; Rolf R. Engel, Ph.D.; Werner Kissling, M.D.
A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Michael A. Posternak, M.D.; Mark Zimmerman, M.D.; Gabor I. Keitner, M.D.; Ivan W. Miller, Ph.D.
Neuropsychological Correlates of Hippocampal Volumes in Patients Experiencing a First Episode of Schizophrenia
Philip R. Szeszko, Ph.D.; Rael D. Strous, M.D.; Robert S. Goldman, Ph.D.; Manzar Ashtari, Ph.D.; Kevin H. Knuth, Ph.D.; Jeffrey A. Lieberman, M.D.; Robert M. Bilder, Ph.D.
A PET Study of the Pathophysiology of Negative Symptoms in Schizophrenia
Steven G. Potkin, M.D.; Gustavo Alva, M.D.; Kirsten Fleming, Ph.D.; Ravi Anand, M.D.; David Keator, M.C.S.; Danilo Carreon, M.D.; Michael Doo, B.S.; Yi Jin, M.D.; Joseph C. Wu, M.D.; James H. Fallon, Ph.D.
Minor Physical Anomalies and Schizophrenia Spectrum Disorders: A Prospective Investigation
Jason Schiffman, M.A.; Morten Ekstrom, M.D.; Joseph LaBrie, M.A.; Fini Schulsinger, M.D.; Holger Sorensen, M.D; Sarnoff Mednick, Ph.D., Dr.Med.
Volume Changes in Gray Matter in Patients With Schizophrenia
Hilleke E. Hulshoff Pol, Ph.D.; Hugo G. Schnack, Ph.D.; Madelief G.B.C. Bertens, M.S.; Neeltje E.M. van Haren, M.S.; Ingeborg van der Tweel; Wouter G. Staal, M.D., Ph.D.; Wim F.C. Baaré, Ph.D.; René S. Kahn, M.D., Ph.D.
Anterior Cingulate Activation During Stroop Task Performance: A PET to MRI Coregistration Study of Individual Patients With Schizophrenia
Murat Yücel, Ph.D.; Christos Pantelis, M.R.C.Psych., F.R.A.N.Z.C.P.; Geoffrey W. Stuart, Ph.D.; Stephen J. Wood, Ph.D.; Paul Maruff, Ph.D.; Dennis Velakoulis, F.R.A.N.Z.C.P.; Andrew Pipingas, M.A.; Simon F. Crowe, Ph.D.; Henri J. Tochon-Danguy, Ph.D.; Gary F. Egan, Ph.D., M.B.A.
Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder
Jan Volavka, M.D., Ph.D.; Pal Czobor, Ph.D.; Brian Sheitman, M.D.; Jean-Pierre Lindenmayer, M.D.; Leslie Citrome, M.D., M.P.H.; Joseph P. McEvoy, M.D.; Thomas B. Cooper, M.A.; Miranda Chakos, M.D.; Jeffrey A. Lieberman, M.D.
Symptom Stability in Adult Obsessive-Compulsive Disorder: Data From a Naturalistic Two-Year Follow-Up Study
David Mataix-Cols, Ph.D.; Scott L. Rauch, M.D.; Lee Baer, Ph.D.; Jane L. Eisen, M.D.; David M. Shera, Sci.D.; Wayne K. Goodman, M.D.; Steven A. Rasmussen, M.D.; Michael A. Jenike, M.D.
Prospective Long-Term Follow-Up of 44 Patients Who Received Cingulotomy for Treatment-Refractory Obsessive-Compulsive Disorder
Darin D. Dougherty, M.D., M.Sc.; Lee Baer, Ph.D.; G. Rees Cosgrove, M.D.; Edwin H. Cassem, M.D.; Bruce H. Price, M.D.; Andrew A. Nierenberg, M.D.; Michael A. Jenike, M.D.; Scott L. Rauch, M.D.
Functional Impairment in Patients With Schizotypal, Borderline, Avoidant, or Obsessive-Compulsive Personality Disorder
Andrew E. Skodol, M.D.; John G. Gunderson, M.D.; Thomas H. McGlashan, M.D.; Ingrid R. Dyck, M.P.H.; Robert L. Stout, Ph.D.; Donna S. Bender, Ph.D.; Carlos M. Grilo, Ph.D.; M. Tracie Shea, Ph.D.; Mary C. Zanarini, Ed.D.; Leslie C. Morey, Ph.D.; Charles A. Sanislow, Ph.D.; John M. Oldham, M.D.
Confirmatory Factor Analysis of DSM-IV Criteria for Borderline Personality Disorder: Findings From the Collaborative Longitudinal Personality Disorders Study
Charles A. Sanislow, Ph.D.; Carlos M. Grilo, Ph.D.; Leslie C. Morey, Ph.D.; Donna S. Bender, Ph.D.; Andrew E. Skodol, M.D.; John G. Gunderson, M.D.; M. Tracie Shea, Ph.D.; Robert L. Stout, Ph.D.; Mary C. Zanarini, Ed.D.; Thomas H. McGlashan, M.D.
A Factor Analysis of Tic Symptoms in Gilles de la Tourette’s Syndrome
John P. Alsobrook, II, Ph.D.; David L. Pauls, Ph.D.
Higher Prevalence of Antibodies to Borrelia Burgdorferi in Psychiatric Patients Than in Healthy Subjects
Tomáš Hájek, M.D.; Beáta Pašková, M.D.; Daniela Janovská, M.D.; Radvan Bahbouh, M.D.; Peter Hájek, Ph.D.; Jan Libiger, M.D.; Cyril Höschl, M.D., M.R.C.Psych.
Impaired Recognition of Facial Emotion in Mania
Anna Lembke, M.D.; Terence A. Ketter, M.D.
Limbic Hyperreactivity in Bipolar II Disorder
Gregory S. Berns, M.D., Ph.D.; Megan Martin, B.A.; Shawnette M. Proper, B.S.
Age at Onset, Childhood Psychopathology, and 2-Year Outcome in Psychotic Bipolar Disorder
Gabrielle A. Carlson, M.D.; Evelyn J. Bromet, Ph.D.; Corine Driessens, M.A.; Ramin Mojtabai, M.D., Ph.D.; Joseph E. Schwartz, Ph.D.
Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
Christopher H. van Dyck, M.D.; Donald M. Quinlan, Ph.D.; Lisa M. Cretella, M.A.; Julie K. Staley, Ph.D.; Robert T. Malison, M.D.; Ronald M. Baldwin, Ph.D.; John P. Seibyl, M.D.; Robert B. Innis, M.D., Ph.D.
Clozapine-Induced Stuttering and Seizures
HARPREET S. DUGGAL, M.B.B.S., D.P.M.; K. JAGADHEESAN, M.B.B.S., M.D.; S. HAQUE NIZAMIE, M.D., D.P.M.
Transcranial Magnetic Stimulation for Panic
PETER ZWANZGER, M.D.; CHRISTO MINOV, M.D.; ROBIN ELLA, M.D.; CORNELIUS SCHÜLE, M.D.; THOMAS BAGHAI, M.D.; HANS-JÜRGEN MÖLLER, M.D.; RAINER RUPPRECHT, M.D.; FRANK PADBERG, M.D.
Nortriptyline for Depression and Vulvodynia
ANDREA G. STOLAR, M.D.; JONATHAN T. STEWART, M.D.
Clozapine for First-Episode Schizophrenia
THEODORE T. KOLIVAKIS, M.D., C.M., F.R.C.P.(C.); HOWARD C. MARGOLESE, M.D., C.M., F.R.C.P.(C.); LINDA BEAUCLAIR, M.D., F.R.C.P.(C.); GUY CHOUINARD, M.D., M.SC., F.R.C.P.(C.)
Mania in Hyperandrogenism, Insulin Resistance, and Nigricans Acanthosis Syndrome
YIU-CHUNG CHAN, M.D.; MARY BETH HANKINS, L.I.S.W.; BEVILA JOHN-DANIEL, M.D.
Suicide Attempt After Use of Herbal Diet Pill
AMMAR S. TRABOULSI, M.D.; RAMASWAMY VISWANATHAN, M.D., D.SC.; JEREMY COPLAN, M.D.
Antistreptolysin-O Titers: Implications for Adult PANDAS
ANDREW J. CHURCH, B.SC.; RUSSELL C. DALE, M.B.CH.B., M.R.C.P.
Pramipexole for Depression
MORTIMER OSTOW, M.D.
Benzodiazepine Discontinuation in Generalized Anxiety Disorder
RAHUL GUPTA, M.D.; NITIN GUPTA, M.D.; AJIT AVASTHI, M.D.
Dr. Rickels and Colleagues Reply
KARL RICKELS, M.D.; NICKOLAS DEMARTINIS, M.D.; J. FELIPE GARCÍA-ESPAÑA, PH.D.; DAVID J. GREENBLATT, M.D.; LAURA MANDOS, PHARM.D.; MOIRA RYNN, M.D.
Dr. Di Maggio and Colleagues Reply
CAROLE DI MAGGIO, M.D.; MARIA MARTINEZ, PH.D.; JEAN-FRANÇOIS MÉNARD, PH.D.; MICHEL PETIT, M.D.; FLORENCE THIBAUT, M.D., PH.D.
Early Onset of Schizophrenia
JARI HAUKKA, PH.D.; JAANA SUVISAARI, PH.D., M.D.; JOUKO LÖNNQVIST, PH.D., M.D.
Quetiapine and Cataracts
ALAN M. LATIES, M.D.
Clozapine and Suicide
HERBERT MELTZER, M.D.
Clozapine and Suicide
AYGUN ERTUGRUL, M.D.
Clozapine and Dopamine D2 Blockade
LYN S. PILOWSKY, PH.D., M.R.C.PSYCH.; PETER J. ELL, M.D., M.SC., P.D., F.R.C.R., F.R.C.P.
Dr. Sernyak and Colleagues Reply
MICHAEL J. SERNYAK, M.D.; RANI DESAI, PH.D.; ROBERT ROSENHECK, M.D.
Dr. Talvik and Colleagues Reply
MIRJAM TALVIK, M.D.; ANNA-LENA NORDSTRÖM, M.D., PH.D.; SVANTE NYBERG, M.D., PH.D.; HANS OLSSON, M.D.; CHRISTER HALLDIN, PH.D.; LARS FARDE, M.D., PH.D.
Outcome of Asperger’s Syndrome
HARPREET S. DUGGAL, M.B.B.S., D.P.M.; SIDDHARTHA DUTTA, M.D., D.P.M.; VINOD K. SINHA, M.D., D.P.M.
The Human Genome: Proteomics
Jan Van Oostrum, Ph.D.; Hans Voshol, Ph.D.
Max Schur, M.D., 1897–1969
Stephen M. Wittenberg, M.D.; Lewis M. Cohen, M.D.